Diagnostic Criteria and Management of Delirium Tremens

Core Diagnostic Features

The American College of Hepatology recommends that delirium tremens (DT) is diagnosed when severe alcohol withdrawal symptoms, including tremor, sweating, tachycardia, and hypertension, occur together with delirium features, such as altered mental status, disorientation, and fluctuating symptoms, typically peaking 3-5 days after alcohol cessation 1
Autonomic hyperactivity, characterized by tachycardia, hypertension, high fever, and profuse sweating, is a key component of DT 1
Tremor, particularly hand tremor, is a common symptom of DT 1
Gastrointestinal symptoms, including nausea and vomiting, are also associated with DT 1
The delirium component of DT is characterized by acute onset and fluctuating course, with symptoms varying substantially throughout the day, and altered level of consciousness, ranging from hypervigilance to reduced arousal 2
Disorganization of thought and disorientation to person, place, or time are also key features of the delirium component of DT 1

Symptoms of DT typically begin 6-24 hours after abrupt cessation of alcohol in chronic heavy drinkers and peak in severity at 3-5 days following alcohol cessation 1
The Confusion Assessment Method (CAM) is a validated tool for general delirium diagnosis, with 82-100% sensitivity and 89-99% specificity, but the CIWA protocol is not recommended for diagnosing DT due to its low specificity 2, 1

DT is distinguished from general delirium by its association with alcohol cessation in dependent individuals and prominent autonomic hyperactivity 1
DT is also distinguished from alcohol withdrawal seizures by the presence of altered mental status and delirium 1
Concurrent medical comorbidities, including liver disease, infection, dehydration, and electrolyte imbalances, increase the risk of developing DT 1

Immediate evaluation for life-threatening complications, including vital signs monitoring, dehydration, electrolyte disturbances, renal failure, infection, gastrointestinal bleeding, pancreatitis, hepatic failure, and head trauma, is essential in patients with DT 1, 4
Long-acting benzodiazepines, such as diazepam or chlordiazepoxide, are first-line treatment for preventing seizures and managing symptoms of DT, while lorazepam is preferred for patients with severe DT, advanced age, or recent head trauma 1
Psychiatric consultation is recommended for acute management and long-term abstinence planning in patients with DT 1